Climbing Pharma’s Real-World Data Maturity Curve

Climbing Pharma’s Real-World Data Maturity Curve

Viraj Narayanan, CEO at Cornerstone AI Daniel Lane, Head of RWD Strategy & Operations at Bristol Myers Squibb Real-world data (RWD) has become the pharmaceutical industry’s most promising yet challenging frontier. While companies have long recognized its potential to complement clinical trials and deepen patient outcome insights, many still struggle to fully realize its value. We’ve seen firsthand, from early discovery to market authorization to…

The Critical Role of Connected Data in Modern QMS for Medical Devices

The medical device industry is operating within an increasingly complex regulatory environment. With the growing emphasis on patient safety, cybersecurity, and post-market surveillance, regulators such as the FDA, EMA, and other global authorities have heightened their scrutiny of data integrity and traceability throughout the product lifecycle. Quality Management Systems (QMS) that once relied on disparate, manually updated records are no longe…